XML 41 R31.htm IDEA: XBRL DOCUMENT v3.23.1
Stockholders’ Equity (Tables)
 3 Months Ended
Mar. 31, 2023
Share-Based Payment Arrangement [Abstract]  
Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions
The grant date fair value of the Company’s stock options granted (excluding the stock options granted to the CEO outlined above) was estimated using the following weighted average assumptions for the three months ended March 31, 2023:
 
Expected term (in years)6.02
Expected volatility49.9 %
Risk-free interest rate4.2 %
Expected dividend yield— %
Share-based Payment Arrangement, Option, Activity
Option activity (excluding the stock options granted to the CEO outlined above) is as follows (in thousands, except for weighted average exercise price and weighted average contractual term in years):
 
SharesWeighted
Average
Exercise
Price		Weighted
Average
Contractual
Period
(in Years)		Aggregate
Intrinsic
Value
Outstanding at December 31, 202214,450 $4.68 7.98$35,771 
Granted603 11.53 
Exercised(95)1.76 
Forfeited and expired(38)11.33 
Outstanding at March 31, 202314,920 4.97 7.8478,114 
Exercisable as of March 31, 20238,995 3.97 7.0855,224 
Share-based Payment Arrangement, Option, Exercise Price Range
The options outstanding and exercisable as of March 31, 2023 (excluding the stock options granted to the CEO outlined above) have been aggregated into ranges for additional disclosure as follows (in thousands, except weighted average remaining contractual life and exercise price):
 
 Options OutstandingOptions Exercisable
Exercise PriceSharesWeighted Average Remaining Contractual Life 
(in Years)		SharesWeighted Average Remaining Contractual Life 
(in Years)
$ 0.06 – 0.40
1,807 4.971,807 4.97
1.55 – 1.75
895 6.24895 6.24
2.43 – 3.11
3,035 7.252,951 7.20
5.01 – 6.82
6,188 8.971,582 8.92
8.13 – 11.53
2,153 8.431,321 7.76
12.21 – 15.17
842 7.99439 7.91
14,920 8,995 
Share-based Payment Arrangement, Restricted Stock Unit, Activity
RSU activity (excluding the 2023 performance RSUs outlined below) is as follows (in thousands, except for weighted average grant date fair value):

SharesWeighted Average Grant Date Fair Value
Unvested at December 31, 202211,601 $6.40 
Granted6,800 10.45 
Vested(1,157)6.41 
Forfeited and expired(281)6.91 
Unvested at March 31, 202316,963 $7.95 
Share-based Payment Arrangement, Expensed and Capitalized, Amount
The following table summarizes stock-based compensation expense for employees and nonemployees, by category, on the condensed consolidated statements of operations and comprehensive loss for the three months ended March 31, 2023 and 2022 (in thousands):
Three Months Ended March 31,
20232022
Marketing$996 $823 
Operations and support1,154 486 
Technology and development1,461 906 
General and administrative10,556 6,641 
Total stock-based compensation expense$14,167 $8,856